BioMerieux Income from Continuous Operations 2017-2024 | BMXMF
BioMerieux annual/quarterly income from continuous operations history and growth rate from 2017 to 2024. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
- BioMerieux income from continuous operations for the quarter ending December 31, 2024 was $0M, a 0% increase year-over-year.
- BioMerieux income from continuous operations for the twelve months ending December 31, 2024 was $0M, a 0% increase year-over-year.
- BioMerieux annual income from continuous operations for 2024 was $0.46B, a 31.67% increase from 2023.
- BioMerieux annual income from continuous operations for 2023 was $0.349B, a 26.91% decline from 2022.
- BioMerieux annual income from continuous operations for 2022 was $0.478B, a 32.46% decline from 2021.
| BioMerieux Annual Income from Continuous Operations (Millions of US $) |
|
|---|---|
| 2024 | $460 |
| 2023 | $349 |
| 2022 | $478 |
| 2021 | $708 |
| 2020 | $460 |
| 2019 | $302 |
| 2018 | $302 |
| 2017 | $269 |
| 2016 | $198 |
| 2015 | $0 |
| BioMerieux Quarterly Income from Continuous Operations (Millions of US $) |
|
|---|---|
| 2024-12-31 | |
| 2024-06-30 | |
| 2023-12-31 | |
| 2023-06-30 | |
| 2022-12-31 | |
| 2022-06-30 | |
| 2021-12-31 | |
| 2021-06-30 | |
| 2020-12-31 | |
| 2019-12-31 | |
| 2019-06-30 | |
| 2018-12-31 | |
| 2018-06-30 | |
| 2017-12-31 | |
| 2017-06-30 | |
| 2016-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $17.068B | $4.307B |
| bioM?rieux S.A. designs, develops, manufactures and markets systems in the field of vitro diagnostics. The company provides diagnostic solutions which determine the source of disease and contamination. It also offers solutions for managing infectious diseases, cancers and cardiovascular diseases in clinical applications. The company provides solutions for the enumeration of microbial flora, detection of specific pathogenic bacteria, monitoring of air and surface quality and sterility testing for the agri-food, cosmetics and pharmaceutical industries. bioM?rieux S.A. is based in Marcy L Etoile, France. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $145.316B | 26.95 |
| CVS Health (CVS) | United States | $75.446B | 9.38 |
| Elevance Health (ELV) | United States | $64.396B | 8.66 |
| Cencora (COR) | United States | $55.472B | 19.30 |
| DiDi Global (DIDIY) | China | $25.980B | 27.60 |
| Labcorp Holdings (LH) | United States | $21.919B | 17.30 |
| Natera (NTRA) | United States | $18.843B | 0.00 |
| ICON (ICLR) | Ireland | $15.316B | 14.74 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.929B | 0.00 |
| CochLear (CHEOY) | Australia | $13.403B | 0.00 |
| Solventum (SOLV) | United States | $12.763B | 13.51 |
| Medpace Holdings (MEDP) | United States | $12.728B | 33.68 |
| Revvity (RVTY) | United States | $11.202B | 19.44 |
| Viatris (VTRS) | United States | $10.868B | 3.73 |
| Avantor (AVTR) | United States | $9.533B | 13.85 |
| Sonic Healthcare (SKHHY) | Australia | $9.208B | 0.00 |
| Charles River Laboratories (CRL) | United States | $8.791B | 17.23 |
| HealthEquity (HQY) | United States | $8.281B | 36.27 |
| Caris Life Sciences,�Inc (CAI) | United States | $6.884B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $5.109B | 30.08 |
| BrightSpring Health Services (BTSG) | United States | $3.600B | 33.03 |
| Sotera Health (SHC) | United States | $3.489B | 19.82 |
| Surgery Partners (SGRY) | United States | $2.876B | 37.40 |
| Organon (OGN) | United States | $2.592B | 2.75 |
| Concentras Parent (CON) | United States | $2.576B | 14.89 |
| GeneDx Holdings (WGS) | United States | $2.423B | 93.31 |
| Alignment Healthcare (ALHC) | United States | $2.346B | 0.00 |
| Progyny (PGNY) | United States | $1.989B | 43.77 |
| PACS (PACS) | United States | $1.792B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.789B | 35.79 |
| Premier (PINC) | United States | $1.739B | 13.20 |
| Ardent Health (ARDT) | United States | $1.525B | 6.50 |
| Teladoc Health (TDOC) | United States | $1.439B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.228B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.088B | 8.28 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.875B | 300.00 |
| Agilon Health (AGL) | United States | $0.824B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.753B | 7.05 |
| CareDx (CDNA) | United States | $0.712B | 11.12 |
| Embecta (EMBC) | United States | $0.662B | 4.46 |
| Nutex Health (NUTX) | United States | $0.513B | 7.77 |
| So-Young (SY) | China | $0.513B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.506B | 0.00 |
| LifeMD (LFMD) | United States | $0.494B | 0.00 |
| Omada Health (OMDA) | $0.478B | 0.00 | |
| SBC Medicals (SBC) | United States | $0.477B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.467B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.457B | 10.28 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.406B | 0.00 |
| Enhabit (EHAB) | United States | $0.344B | 28.29 |
| Oncology Institute (TOI) | United States | $0.336B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.286B | 0.00 |
| Beauty Health (SKIN) | United States | $0.222B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.204B | 0.00 |
| DocGo (DCGO) | United States | $0.152B | 24.83 |
| Sera Prognostics (SERA) | United States | $0.118B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.086B | 0.00 |
| KindlyMD (NAKA) | United States | $0.077B | 0.00 |
| Biodesix (BDSX) | United States | $0.061B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.060B | 0.00 |
| ModivCare (MODV) | United States | $0.044B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.042B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.041B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.018B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.011B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |